For digital health companies looking to deploy their AI solution into clinical workflows, the potential return-on-investment ...
Hosted on MSN2d
Apellis Pharmaceuticals Faces Financial Challenges Amid Ambitious Drug Commercialization EffortsApellis Pharmaceuticals (APLS) has disclosed a new risk, in the Sales & Marketing category. Apellis Pharmaceuticals is facing a significant ...
If granted, that would enable the commercialization and marketing of the TKA system in the U.S. Shalby Limited Clinical Trial In August 2024, Monogram announced a strategic collaboration with ...
MT Newswires on MSN4h
AbbVie Enters Obesity Market Through Licensing Deal With Denmark's GubraAbbVie (ABBV) on Monday said it struck a licensing deal with Danish biotechnology company Gubra to develop a potential candidate for obesity treatment. AbbVie will be responsible for the global ...
“The commercialization momentum with both new and now repeat customers for our proprietary RenovoCath device has accelerated through expanded relationships with high-volume oncology centers ...
In a city famed for graffiti and murals, rival exhibitions in Belgrade showcasing the impact of British street artist Banksy ...
Ambercycle, an innovator in textile recycling, has entered into a partnership with Zhejiang Huilong New Materials Co., Ltd., ...
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, a novel, FDA-cleared drug-delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback